iBio
IBIO
#9822
Rank
NZ$80.26 M
Marketcap
NZ$3.57
Share price
12.57%
Change (1 day)
-12.03%
Change (1 year)

iBio (IBIO) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$0.11 Billion

According to iBio's latest financial reports the company's total assets are NZ$0.11 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

iBio - Total assets on balance sheet (from 2008 to 2025)

Total assets by year

Year Total assets Change
2024-06-30NZ$47.11 M-29.88%
2023-06-30NZ$67.18 M-57.83%
2022-06-30NZ$0.15 B-24.16%
2021-06-30NZ$0.21 B43.87%
2020-06-30NZ$0.14 B220.94%
2019-06-30NZ$45.49 M-28.49%
2018-06-30NZ$63.61 M29.34%
2017-06-30NZ$49.18 M-31.98%
2016-06-30NZ$72.3 M292.79%
2015-06-30NZ$18.4 M148.4%
2014-06-30NZ$7.41 M-38.7%
2013-06-30NZ$12.08 M-0.65%
2012-06-30NZ$12.16 M37.4%
2011-06-30NZ$8.85 M24.25%
2010-06-30NZ$7.12 M-7.32%
2009-06-30NZ$7.69 M64.83%
2008-06-30NZ$4.66 M-4.82%
2007-06-30NZ$4.9 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Genocea Biosciences
GNCA
NZ$67.2 M-39.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.53 B 2,177.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$334.07 B 300,447.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ$0.52 B 369.72%๐Ÿ‡บ๐Ÿ‡ธ USA